Category: Parkinson’s News

From island walks to lengthy bike rides, and even a spot of canyoning – our fundraisers took on some incredible challenges for us in June! Walking the

Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far surpassing previous efforts that produced only a few dozen. By systematically experimenting with combinations of morphogens and gene regulators, the researchers replicated the vast diversity of neurons found in the human brain. This breakthrough holds major promise for studying neurological diseases like Alzheimer’s and Parkinson’s, creating more accurate models for drug testing, and eventually even enabling neuron replacement therapies.

Could we stop Parkinson’s by feeding neurons copper?

The Join Parkinson’s Research (JPR) registry is a new online platform where people living with the condition can register to hear about the latest

UD study explores laser therapy to treat Parkinson’s

Northwestern Medicine find HPgV in brain samples of people with Parkinson’s, not in those without.

For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.

New research from Northwestern Medicine detects a common, but usually harmless virus in the brains of Parkinson’s patients

Parkinson’s disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have demonstrated that this initial side of onset influences the progression of non-motor symptoms.

A safe and affordable treatment to slow the advancement of Parkinson’s dementia has emerged – in the form of a commonly available cough syrup that’s already being studied for its positive effect on other degenerative diseases.